Related Experiment Video
Updated: Aug 6, 2025
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
Immunogenicity of the Non-toxic Form of Staphylococcus Aureus α-Hemolysin Using a Chimeric Fusion in Mice
Liquan Yu1, Jian Dai1, Fan Ziyao1
1School of Life Science and Biotechnology, Heilongjiang Bayi Agricultural University, Daqing 163319, Heilongjiang, China.
Background:
Staphylococcus aureus is an opportunistic pathogen responsible for various infections with diverse clinical presentation and severity. The α-hemolysin is a major virulence factor in the pathogenesis of S. aureus infections.
Objective:
To produce a chimeric fusion protein for hemolytic detection of the S. aureus isolates and as a component of a multi-antigen vaccine.
Methods:
The fused strategy employed a flexible linker to incorporate the possible B cell and T cell determinants into one chimera (HlaD). The humoral and cellular response to the HlaD in mice was assessed to reveal a non-significant difference compared with the full-length α-hemolysin mutant (Hla H35L).
Results:
The results of the protective effect, the mimetic lung cell injury, and bacterial clearness demonstrated that the mice vaccinated with the HlaD alleviated the severity of the infection of the S. aureus, and the HlaD could similarly function with Hla H35L.
Conclusion:
The chimeric fusion (HlaD) provided a diagnostic antigen for hemolysis of the S. aureus strains and a potential vaccine component.
Insights
A novel chimeric fusion protein, HlaD, shows promise for detecting Staphylococcus aureus and as a vaccine component. This HlaD antigen effectively alleviates S. aureus infection severity in mice.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Staphylococcus aureus is an opportunistic pathogen causing diverse infections.
- Alpha-hemolysin (Hla) is a key virulence factor in S. aureus pathogenesis.
Purpose of the Study:
- Develop a chimeric fusion protein (HlaD) for S. aureus hemolytic detection.
- Evaluate HlaD as a potential component for a multi-antigen vaccine.
Main Methods:
- A flexible linker incorporated B and T cell determinants into the HlaD chimera.
- Humoral and cellular responses to HlaD were assessed in mice.
- Compared HlaD response to a full-length alpha-hemolysin mutant (Hla H35L).
Main Results:
- HlaD vaccination in mice alleviated S. aureus infection severity.
- Protective effects included reduced lung cell injury and improved bacterial clearance.
- HlaD demonstrated comparable function to Hla H35L.
Conclusions:
- The chimeric fusion HlaD serves as a diagnostic antigen for S. aureus strains.
- HlaD is a potential candidate for vaccine development against S. aureus infections.
More Related Videos
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015